Your browser doesn't support javascript.
loading
The history of antivenoms development: Beyond Calmette and Vital Brazil.
Squaiella-Baptistão, Carla Cristina; Sant'Anna, Osvaldo Augusto; Marcelino, José Roberto; Tambourgi, Denise V.
Afiliação
  • Squaiella-Baptistão CC; Immunochemistry Laboratory, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil.
  • Sant'Anna OA; Immunochemistry Laboratory, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil.
  • Marcelino JR; Hyperimmune Plasma Section, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil.
  • Tambourgi DV; Immunochemistry Laboratory, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil. Electronic address: denise.tambourgi@butantan.gov.br.
Toxicon ; 150: 86-95, 2018 Aug.
Article em En | MEDLINE | ID: mdl-29778595
This review presents the main contributions to our knowledge regarding the development of antivenoms for therapeutic use in victims of venomous animal bites. We cover the progress of serum therapy since tetanus and diphtheria antitoxins in Germany and France until the current scenario of antivenom production worldwide. During these more than 120 years of antivenom development, many researchers contributed to establish what are nowadays the antivenoms used for therapeutic purpose. The history of antivenoms development is fascinating! This review aims to recognize all those who contributed to the establishment of new sera, new methodologies and saving lives: much more than Calmette and Vital Brazil.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivenenos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivenenos Idioma: En Ano de publicação: 2018 Tipo de documento: Article